Position in BLTE
as of Mar 31, 2026
· filed May 29, 2026
Position Value
$24,231,531
-$42,030,139 QoQ
Shares Held
151,979
-63.3% QoQ
Ownership
0.379%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BLTE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PERCEPTIVE ADVISORS LLC holds $4,570,707,559 across 67 Biotechnology names. BLTE ranks #40 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRAX |
Praxis Precision Medicines, Inc.
|
2,035,986 | $655,974,329 | |
| 2 | CELC |
Celcuity Inc.
|
3,127,200 | $356,938,608 | |
| 3 | ASND |
Ascendis Pharma A/S
|
1,531,421 | $350,281,925 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
8,285,461 | $229,507,269 | |
| 5 | CNTA |
Centessa Pharmaceuticals plc
|
5,258,903 | $208,883,627 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,373,795 | $206,448,951 | |
| 7 | SYRE |
Spyre Therapeutics, Inc.
|
3,783,225 | $190,825,869 | |
| 8 | NUVL |
Nuvalent, Inc.
|
1,580,505 | $161,922,737 |
All Filings in BLTE
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $24,231,531 | 151,979 | Shares | Sole | 2026-05-29 | |
| 2025-12-31 | $66,261,670 | 414,239 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,684,312 | 49,788 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||